Intensity TherapeuticsINTS
13F holders, Q4 2025 (December 31)35holders +9
9new positions
1sold out
$0.40avg. 13F price*
At the end of Q4 2025, 35 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings, up 9 from Q3 2025. 9 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($266K), Sapient Capital LLC ($244K) and Rothschild Wealth LLC ($203K).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $218K |
| Exits | 1 | $6K |
All 13F filers, Q3 2025 → Q4 2025: 1,476,125 shares bought and 532,151 shares sold, net +943,974 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Vanguard Group Inc. | 0.00% | Add +153.6% | 649,084 | $266K |
| Sapient Capital LLC | 0.00% | Reduce -33.4% | 650,151 | $244K |
| Rothschild Wealth LLC | 0.02% | Add +3.1% | 495,910 | $203K |
| Geode Capital Management, LLC | 0.00% | Add +77.8% | 460,248 | $189K |
| Mesirow Financial Investment Management, Inc. | 0.00% | Add +25.5% | 251,000 | $103K |
| Legacy Advisors, LLC | 0.01% | New | 153,447 | $63K |
| Creative Planning | 0.00% | New | 143,136 | $59K |
| State Street Corp. | 0.00% | Add +839.3% | 136,200 | $56K |
| Brown Advisory Inc. | 0.00% | Reduce -0.1% | 130,000 | $53K |
| Corient Private Wealth LP | 0.00% | New | 100,000 | $41K |
| Stonebridge Financial Group, LLC | 0.00% | Add +42.3% | 77,377 | $32K |
| Northern Trust Corp. | 0.00% | Add +438.7% | 75,543 | $31K |
| Warberg Asset Management LLC | 0.09% | Add +15.0% | 69,000 | $28K |
| Jane Street Group, LLC | 0.00% | New | 62,755 | $26K |
| Sigma Planning Corp | 0.00% | Reduce -18.4% | 56,432 | $23K |
| IHT Wealth Management, LLC | 0.00% | Add +6.3% | 50,483 | $21K |
| Virtu Financial LLC | 0.00% | Add +87.6% | 48,722 | $20K |
| Ewa, LLC | 0.00% | Add +115.2% | 41,354 | $17K |
| Two Sigma Securities, LLC | 0.00% | Add +88.8% | 34,829 | $14K |
| One Charles Private Wealth Services, LLC | 0.00% | No change | 31,800 | $13K |
| Blair William & Co. | 0.00% | Reduce -20.1% | 30,191 | $12K |
| UBS Group AG | 0.00% | Reduce -81.4% | 25,397 | $10K |
| NewEdge Advisors, LLC | 0.00% | New | 25,000 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +29.0% | 21,532 | $9K |
| QTR Family Wealth, LLC | 0.00% | No change | 17,420 | $7K |
| Sassicaia Capital Advisers LLC | 0.01% | Reduce -25.0% | 15,000 | $6K |
| Marex Group Ltd | 0.00% | New | 15,000 | $6K |
| T3 Companies, LLC | 0.01% | — | 13,600 | $6K |
| Vontobel Holding Ltd. | 0.00% | New | 12,000 | $5K |
| Beacon Pointe Advisors, LLC | 0.00% | New | 10,199 | $4K |
| World Investment Advisors | 0.00% | New | 10,000 | $4K |
| CIBC Private Wealth Group LLC | 0.00% | Add +0.5% | 5,025 | $2K |
| Bank of America Corp. | 0.00% | Reduce -5.8% | 584 | $240 |
| Morgan Stanley | 0.00% | No change | 500 | $205 |
| Citigroup Inc. | 0.00% | Reduce -99.8% | 88 | $36 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.